Gnanapavan S, Ho P, Heywood W, Jackson S, Grant D, Rantell K, Keir G, Mills K, Steinman L, Giovannoni G. Progression in multiple sclerosis i...
Research Biomarker for Progression
Info Post
Gnanapavan S, Ho P, Heywood W, Jackson S, Grant D, Rantell K, Keir G, Mills K, Steinman L, Giovannoni G. Progression in multiple sclerosis i...
#MSBlog : Preventing vascular disease may impact on the course of MS; vD supplements may be one way of doing this! "At the recent IPMSC...
#MSBlog : Why do relapse on and off a DMT mean something different? We need a serious discussion on this topic! Scalfari et al. Early relaps...
Cadavid D, Jurgensen S, Lee S. Impact of natalizumab on ambulatory improvement in secondary progressive and disabled relapsing-remitting mu...
Kallaur AP, Oliveira SR, Colado Simão AN, Delicato de Almeida ER, Kaminami Morimoto H, Lopes J, de Carvalho Jennings Pereira WL, Marques And...